Stock screenerAll disclosures →
EDGAR →
EVMN
Conviction 0HealthcareScan · Mon, Aug 10, 2026EVMN$14.07-0.07%
ResistanceSupportVol 14Insider buyInsider sell2
2
2
Vol MA14 541.54K
May 11May 28Jun 16Jul 6Jul 23Aug 10
Price14.07
Change-0.07%
Gap-1.07%
Rel volume0.41×
Avg volume578.76K
Avg $ vol7.01M
SMA 2012.09
SMA 5016.07
SMA 200—
Price vs 50-12.44%
Price vs 200—
MA stack—
50/200 cross—
Supertrendup · 11.19
RSI (14)54
MACD hist0.64
MACD cross—
Stoch %K / %D93 / 93
ADX (14)28
+DI / −DI25 / 20
RSI divergenceBullish
MACD divergenceBullish
ATR %+7.28%
ADR %6.70%
52w high31.57
52w low11.05
From 52w high-55.43%
Above 52w low+27.33%
New 52w highNo
SqueezeOff
Bollinger width30.82%
%B1.03
Donchian pos92.54%
Donchian high14.36
Donchian low10.47
AVWAP (52w high)21.03
vs AVWAP high-33.10%
AVWAP (52w low)12.11
vs AVWAP low+16.21%
OBV trendFlat
Chaikin MF (20)0.19
Today vs 20d0.41×
Avg vol (14d)541.54K
Avg vol (20d)578.76K
Avg $ vol (20d)7.01M
Market cap510.63M
RS 3m (vs SPY)-43.12%
RS 6m (vs SPY)-29.60%
RS line new highNo
Trend template—
Technical rank39.8
1 week+21.40%
1 month+6.51%
3 months-38.61%
6 months-18.72%
1 year—
YTD-18.72%
P/E-7.41
P/B1.84
P/S39.28
P/FCF-6.66
EPS-11.22
Div yield—
ROE-24.81%
ROA-22.81%
Debt/Eq—
Current11.68
EV/EBITDA-5.60
Gross margin—
Net margin-529.77%
Rev growth85.71%
EPS growth-3.09%
Price target34.83
Target upside147.55%
Analyst ratingBuy
Institutional97.23%
Ent. value450.6M
Revenue0
Net income-32.25M
Gross profit—
Free cash flow-76.68M
IndustryBiotechnology
ExchangeNYSE
Shares out36.02M
Employees48
ListedThu, Nov 6, 2025
Free float10.05M
Float %31.9%
Short interest4.02M
Days to cover3.7d
Short volume37.6%
Squeeze score58 / 100
Next earnings—
EPS forecast—
Last EPS vs est−$0.89 vs −$0.68
Last surprise-30.9% miss
Setup gradeD
Conviction0 / 100
Pattern quality—
Tech rank39.8 / 100
Group rank86 / 100 · Leading
Status laneNo active setup
Setup direction—
Pattern family
Resistance19.99
Support10.64
Days since event—
Candle confirm—
News sentiment—
Financials as of Tue, Jun 30, 2026 · quarterly.
Congress activity
Disclosed STOCK Act trades in EVMN
No recent disclosed trades by Congress in EVMN. STOCK Act filings can lag the trade by up to 45 days.
Insider activity
SEC Form 4 transactions in EVMN · 6 buys · 4 sells
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
Carver Kyle Chief Financial Officer · Common Stock · 2026-07-08 | Buy | 1K | $13K | 2026-07-08 | 2026-07-10 |
KIRSCH ARTHUR S Director · Common Stock · 2026-07-07 | Buy | 10K | $133K | 2026-07-07 | 2026-07-08 |
MCGRAW BENJAMIN F III Director · Stock Option (Right to buy) · 2026-06-02 | Grant | 15.67K | $0 | 2026-06-02 | 2026-06-03 |
Cohen David E Director · Common Stock · 2026-06-02 | Sell | 5.46K | $110K | 2026-06-02 | 2026-06-03 |
Cohen David E Director · Common Stock · 2026-06-02 | Sell | 600 | $13K | 2026-06-02 | 2026-06-03 |
Cohen David E Director · Stock Option (Right to buy) · 2026-06-02 | Grant | 15.67K | $0 | 2026-06-02 | 2026-06-03 |
KIRSCH ARTHUR S Director · Stock Option (Right to buy) · 2026-06-02 | Grant | 15.67K | $0 | 2026-06-02 | 2026-06-03 |
Patel Jeegar Pravinkumar Chief Scientific Officer · Common Stock · 2026-06-01 | Sell | 16.69K | $379K | 2026-06-01 | 2026-06-03 |
Patel Jeegar Pravinkumar Chief Scientific Officer · Employee Stock Option (Right to Buy) · 2026-06-01 | Exercise | 13.51K | $0 | 2026-06-01 | 2026-06-03 |
Patel Jeegar Pravinkumar Chief Scientific Officer · Common Stock · 2026-06-01 | Exercise | 13.51K | $52K | 2026-06-01 | 2026-06-03 |
SEC filings
EDGAR filings in EVMN · 10 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.
Start free — 14-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.